Resolving the Controversy Surrounding the Function of the Corrugator Supercilii Muscle.

[INTRODUCTION] The corrugator supercilii muscle (CSM) has traditionally been recognized as a primary depressor of the eyebrows, playing a key role in expressing negative emotions and contributing to the formation of glabellar lines. However, recent studies indicate that the CSM may exhibit movements contrary to those previously documented, suggesting a more complex functional role. This research re-evaluates the anatomical and functional roles of the CSM and discusses their implications for botulinum toxin treatments.

[MATERIAL AND METHODS] A prospective, intrapersonal comparative, and split-face study was conducted over a five-year period, from January 6, 2019, to January 6, 2024, involving 298 patients who underwent botulinum toxin injections. The study divided participants into seven groups, each targeting specific anatomical areas of the CSM and associated muscles. Injection techniques were varied to assess their impact on brow dynamics, with outcomes measured by changes in eyebrow position and expression lines.

[RESULTS] The study demonstrated that targeting specific portions of the CSM and depressor supercilii muscle (DSM) leads to distinct outcomes in brow elevation and the reduction of expression lines. However, this approach was also frequently associated with the development of omega-shaped wrinkles. Split-face evaluations further validated that the modified injection techniques achieved superior eyebrow elevation compared to traditional methods.

[CONCLUSION] This study challenges the traditional view of the CSM as primarily a brow depressor, highlighting its role in medial brow elevation. These findings underscore the need for a nuanced approach in esthetic medicine, particularly in botulinum toxin injections, to achieve balanced and natural facial expressions. Understanding the full range of CSM functions is crucial for optimizing esthetic outcomes and enhancing patient satisfaction.

[LEVEL OF EVIDENCE II] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .